Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LISINOPRIL vs LOMITAPIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LISINOPRIL vs LOMITAPIDE: Safety Overview

Metric LISINOPRIL LOMITAPIDE
Total FAERS Reports 36,869 3,779
Deaths Reported 4,382 109
Death Rate 11.9% 2.9%
Hospitalizations 13,362 434
Average Patient Age 61.5 yrs 54.6 yrs
% Female Patients 51.9% 66.5%
FDA Approval Date Apr 19, 2007 Apr 23, 2015
Manufacturer Legacy Pharmaceutical Packaging, LLC Amryt Pharmaceuticals DAC
Route ORAL ORAL
Marketing Status Discontinued Prescription